AB Science (France) Investor Sentiment

AB Stock  EUR 0.79  0.01  1.25%   
About 61% of AB Science's investor base is looking to short. The analysis of current outlook of investing in AB Science SA suggests that many traders are alarmed regarding AB Science's prospects. The current market sentiment, together with AB Science's historical and current headlines, can help investors time the market. In addition, many technical investors use AB Science SA stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
AB Science announces publication in The Lancet of phase 3 clinical trial results demonstrating masit...
Google News at Macroaxis
over six months ago at news.google.com         
AB Science A new publication in the medical journal Muscle Nerve validates the use of the rate of de...
Google News at Macroaxis
over six months ago at news.google.com         
AB Science FY net loss widens to 27.7 million euros - Reuters
Google News at Macroaxis
over six months ago at news.google.com         
AB Science announces a slight delay in the publication of its 2023 annual financial report - Yahoo F...
Google News at Macroaxis
over six months ago at news.google.com         
Accor SA Short Interest Up 415.8 percent in April - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Scien...
Google News at Macroaxis
over six months ago at news.google.com         
Health Canada Raises Concerns Over AB Sciences ALS Drug Submission - BNN Breaking
Google News at Macroaxis
over six months ago at news.google.com         
AB Science receives notice of allowance for European patent covering masitinib until 2036 in the tre...
Google News at Macroaxis
over six months ago at news.google.com         
Marcel Telles hands son Max his 6.1 billion stake in AB InBev - Fortune
Google News at Macroaxis
over six months ago at news.google.com         
Alzheimers Disease Therapeutics Market size to grow by USD 5.41 billion from 2023-2028 North America...
Google News at Macroaxis
over a year ago at news.google.com         
EPAM Systems, Inc. Short Interest Down 11.0 percent in ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
AB Science will host a live webcast on Thursday November 30, 2023, from 3pm to 4pm CET, to present t...
Google News at Macroaxis
over a year ago at news.google.com         
Ecotoxicological Studies Market Set to Witness Massive Growth ... - Taiwan News
Google News at Macroaxis
over a year ago at news.google.com         
Duni Groups science-based targets approved -November 20, 2023 at 0131 am EST - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Biogas Technology Industry Witness Highest Growth in near Future ... - Argyle Report
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about AB Science that are available to investors today. That information is available publicly through AB Science media outlets and privately through word of mouth or via AB Science internal channels. However, regardless of the origin, that massive amount of AB Science data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AB Science news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AB Science relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AB Science's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AB Science alpha.

AB Science Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for AB Science Stock analysis

When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm